SEC EDGAR filings, ownership reports, and insider transactions for CVF, LLC.
Recent SEC filings for CVF, LLC including SCHEDULE 13G/A, SC 13G/A, SC 13G and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 12 Feb 2025 | |||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 07 Nov 2024 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 14 Feb 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Feb 2024 | 06 Feb 2024 | 001-41942 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 01 Feb 2024 | 01 Feb 2024 | 001-41942 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 10 Feb 2023 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 10 Feb 2023 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 10 Feb 2022 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 10 Feb 2022 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 05 Feb 2021 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | COMPLETE SUBMISSION TEXT FILE | 20 Nov 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 09 Feb 2018 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 - | 19 Jul 2017 | 19 Jul 2017 | 001-38150 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Jul 2017 | 05 Jul 2017 | 001-38130 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 28 Jun 2017 | 28 Jun 2017 | 001-38130 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G AMENDMENT NO. 2 | 10 Feb 2017 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | CERULEAN PHARMA INC. SCHEDULE 13G/A | 10 Feb 2016 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | GENOCEA BIOSCIENCES, INC. SCHEDULE 13G/A | 10 Feb 2016 | ||
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 09 Apr 2015 | 07 Apr 2015 | 001-36395 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | CERULEAN PHARMA INC. SCHEDULE 13G | 17 Feb 2015 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | GENOCEA BIOSCIENCES, INC. SCHEDULE 13G | 17 Feb 2015 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Apr 2014 | 15 Apr 2014 | 001-36395 |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 10 Apr 2014 | 10 Apr 2014 | 001-36395 |
CVF, LLC files with the SEC under CIK 0001112278. This page aggregates EDGAR filings and related ownership activity.